Skip to main content

Advances in the management of inflammatory bowel disease

Buy Article:

$51.00 plus tax (Refund Policy)

Abstract:

Abstract

Our understanding of inflammatory bowel diseases (IBD) is constantly evolving, and many new treatment options have emerged recently. This review critically examines the evidence for these new developments and aims to provide an overview for medical professionals involved in the care of patients with IBD. Proposed changes in the use of aminosalicylates, immunosuppressants and biological agents are described, and the evidence for several promising novel agents is reviewed.

Keywords: Crohn's disease; IBD; review management; ulcerative colitis

Document Type: Research Article

DOI: http://dx.doi.org/10.1111/j.1445-5994.2010.02163.x

Affiliations: Gastroenterology and Hepatology Unit, The Canberra Hospital, Canberra, Australian Capital Territory, Australia

Publication date: April 1, 2010

bsc/imj/2010/00000040/00000004/art00003
dcterms_title,dcterms_description,pub_keyword
6
5
20
40
5

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more